Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

ulcers, infections, feeling weak or tired, cough and diarrhea. Common side effects of Afinitor in patients with SEGA include mouth ulcers, infections of the respiratory tract, sinuses and ears and fever.

Please see full Prescribing Information for Afinitor.

DisclaimerThe foregoing release contains forward-looking statements that can be identified by terminology such as "is being presented," "may," "can," "will," "potential," "ongoing," or similar expressions, or by express or implied discussions regarding potential new indications or labeling for everolimus or regarding potential future revenues from everolimus. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with everolimus to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that everolimus will be submitted or approved for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that everolimus will achieve any particular levels of revenue in the future. In particular, management's expectations regarding everolimus could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; government, industry and general public pricing pressures; competition in general; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and facto
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
(Date:5/23/2013)... 23, 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... of David A. Ramsay ... recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and his ... in our commercial group for the last four ...
(Date:5/23/2013)...  Omeros Corporation (NASDAQ: OMER ) ... (IND) to evaluate OMS824 in Huntington,s disease has ... Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), ... linked to a wide range of diseases that ... has shown promising results in animal models directly ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4
... TORONTO , Jan. 28 MS&L, a ... Patricia Archambault as vice president, healthcare for the ... relationships and healthcare team activities in the office. She will ... healthcare, role is new for the Montreal office ...
... , , WARSAW, Ind. , ... for the fourth quarter increased by 7.5% reported over the prior year period (an ... the fourth quarter were $0.74 reported, a decrease of 1.3% from the ... prior year period , Net Sales of ...
Cached Medicine Technology:MS&L Appoints Patricia Archambault as Vice President, Healthcare in Montreal 2MS&L Appoints Patricia Archambault as Vice President, Healthcare in Montreal 3Zimmer Reports Fourth Quarter and 2009 Financial Results 2Zimmer Reports Fourth Quarter and 2009 Financial Results 3Zimmer Reports Fourth Quarter and 2009 Financial Results 4Zimmer Reports Fourth Quarter and 2009 Financial Results 5Zimmer Reports Fourth Quarter and 2009 Financial Results 6Zimmer Reports Fourth Quarter and 2009 Financial Results 7Zimmer Reports Fourth Quarter and 2009 Financial Results 8Zimmer Reports Fourth Quarter and 2009 Financial Results 9Zimmer Reports Fourth Quarter and 2009 Financial Results 10Zimmer Reports Fourth Quarter and 2009 Financial Results 11Zimmer Reports Fourth Quarter and 2009 Financial Results 12Zimmer Reports Fourth Quarter and 2009 Financial Results 13Zimmer Reports Fourth Quarter and 2009 Financial Results 14Zimmer Reports Fourth Quarter and 2009 Financial Results 15Zimmer Reports Fourth Quarter and 2009 Financial Results 16Zimmer Reports Fourth Quarter and 2009 Financial Results 17Zimmer Reports Fourth Quarter and 2009 Financial Results 18Zimmer Reports Fourth Quarter and 2009 Financial Results 19Zimmer Reports Fourth Quarter and 2009 Financial Results 20Zimmer Reports Fourth Quarter and 2009 Financial Results 21Zimmer Reports Fourth Quarter and 2009 Financial Results 22Zimmer Reports Fourth Quarter and 2009 Financial Results 23Zimmer Reports Fourth Quarter and 2009 Financial Results 24Zimmer Reports Fourth Quarter and 2009 Financial Results 25Zimmer Reports Fourth Quarter and 2009 Financial Results 26Zimmer Reports Fourth Quarter and 2009 Financial Results 27
(Date:5/23/2013)... "triple negative" carries a poor prognosis, with limited treatment ... cancer cells the way it,s supposed to. New research ... respond to chemotherapy, and identifies a mechanism to rectify ... Li, PhD, and his team at Western,s Schulich School ... Numb functions to promote the death of cancer cells ...
(Date:5/23/2013)... Transvaginal mesh lawsuit claims ... move forward in a federal multidistrict litigation underway in ... Liebhard LLP reports. In an Order issued on ... Bard to seal emails that included supplier information the ... proprietary information about its suppliers. The emails were filed ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Former United ... speaker for Acadian 's annual Paramedic Luncheon. ... Lafayette Convention Center, Cheney praised Acadian's medics, saying, "I ... to participate in awarding the Paramedic of the Year ... there is a lot of competition within a company ...
(Date:5/23/2013)... Jackson, TN (PRWEB) May 23, 2013 Spring ... fit, but what’s gotten into Jackson , the city ... variety of new fitness facilities and wellness centers has transformed ... in the state. , “In any city of vibrant, ... to improve or promote health,” said Kim White, owner of ...
(Date:5/23/2013)... FL (PRWEB) May 23, 2013 On April ... in the midst of growing numbers of H7N9 cases and ... Predict H7N9 Bird Flu Cases Will Subside in Northern Hemisphere ... 13th no new cases have been reported. , Quoting ... flu is as predictable as flowers budding in the spring ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3
... beneficial, standardized recommendations for public health.// ... Mayer USDA Human Nutrition Research on Aging (USDA ... Supplements and Chronic Disease Prevention,” outlines challenges and ... and minerals. ,"The evidence regarding vitamin ...
... to redouble its efforts in the fight against HIV and AIDS. ... program on HIV/AIDS, comes after Fiji's Ministry of Health released figures ... and AIDS, reported Fijilive Thursday. ,The figures show that ... 2005 and four cases in 1996. ,UNAIDS Pacific ...
... saves vital immune system cells from cellular suicide during ... keep the body's natural defenses working in HIV-infected people, ... potential new avenue to fight the effects of the ... of Health scientists whose work was published on Monday ...
... of cannabis-like chemicals in the brain of mice were ... in such animals. //This was reported by researchers from ... finding could throw light in the treatment of this ... Nature, a combination of a drug along with cannabis-like ...
... capital city was underwater on Tuesday, and the authorities ... rains, overflowing //rivers and clogged sewers brought widespread flooding ... were reported to have died from drowning, electrocution or ... homes, and hundreds of thousands remained without electricity or ...
... Teenagers fear blindness more than lung cancer or stroke, but ... them of their sight in later life, //reveals research published ... ,The findings are based on the responses of 260 ... venues in Bournemouth, Winchester, Manchester and Southampton. ,One ...
Cached Medicine News:Health News:Effective Marketing of Multivitamins Essential 2Health News:Flood Toll Rises, and Indonesia Braces for Disease 2Health News:Blindness from Smoking Terrifies Teens 2
... Spinal System is intended for use in ... preloaded on its Delivery System - is ... a reduced configuration of 5 mm diameter. ... (depending on the size selected) once it ...
... designed to maximize patient comfort and deliver ... ever to feature Vacuum Pump Deflation Technology. ... reduces the "slamming" effect commonly associated with ... maintains patients comfort and security while treatment ...
... the rescue process by eliminating the need to ... to do is attach the device to a ... are attached to the patient, the device detects ... the patented RHYTHMx software, and if a life-threatening ...
... Electronic Stethoscope Model 2000 is an ... extended frequency range and amplification fourteen ... Littmann stethoscope. This easy-to-use electronic stethoscope ... auscultation. Both superior acoustics and enhanced ...
Medicine Products: